glp 1 serena williams Inside Williams' partnership with Ro for GLP-1s Could Serena Williams' GLP-1 Disclosure

Andres E, Dali-Youcef N, Serraj K et al

Research published in JCI Insight describes tirzepatide as an "imbalanced and biased dual agonist," meaning it actually engages the GIP receptor more potently than the GLP-1 receptor

15 mg-2 group: 35.7%

Specific biological processes are doing the damage: collagen degradation, elastin fragmentation, barrier dysfunction, melanocyte 3 Melanocyte Cell in the epidermis that produces melanin, responsible for pigmentation

Furthermore, the absence of long-term monitoring of endocrine markerssuch as total and free testosterone, luteinizing hormone (LH), and follicle-stimulating hormone(FSH)limits our mechanistic understanding of libido impairment in men with diabetes

However, the effects are temporary, and regular treatments are required to maintain the desired outcome